EPH129 Hospitalization and Healthcare Consumption Burden of Respiratory Syncytial Virus (RSV) in Adults Over 50 years in France (RESVYR Study)

Stephane Fievez; Emmanuelle Blanc; Paul Loubet; Laurence Watier; Louise Baschet; Clélia Bignon-Favary; PIPPA MCKELVIE-SEBILEAU; LAUREN Inchboard; MATHIAS Vacheret

doi:10.1016/j.jval.2025.09.1258

Retour

EPH129 Hospitalization and Healthcare Consumption Burden of Respiratory Syncytial Virus (RSV) in Adults Over 50 years in France (RESVYR Study)

Article de revue

Avec comité de lecture

EPH129 Hospitalization and Healthcare Consumption Burden of Respiratory Syncytial Virus (RSV) in Adults Over 50 years in France (RESVYR Study)

Stephane Fievez, Emmanuelle Blanc, Paul Loubet, Laurence Watier, Louise Baschet, Clélia Bignon-Favary, PIPPA MCKELVIE-SEBILEAU, LAUREN Inchboard et MATHIAS Vacheret

Value in health, Vol.28(12), pp.S289-S289

12/2025

DOI: https://doi.org/10.1016/j.jval.2025.09.1258

Indicateurs

1 Consultations de la notice

Détails

Titre: EPH129 Hospitalization and Healthcare Consumption Burden of Respiratory Syncytial Virus (RSV) in Adults Over 50 years in France (RESVYR Study)
Créateurs - sans rôle: Stephane Fievez - ACCESS AND VALUE -HEOR, Pfizer, Paris, France
Emmanuelle Blanc - VACCINES MEDICAL, PFIZER, Paris, France
Paul Loubet - Université de Montpellier
Laurence Watier - Institut Pasteur
Louise Baschet - HORIANA, Bordeaux, France
Clélia Bignon-Favary - HORIANA, BORDEAUX, France
PIPPA MCKELVIE-SEBILEAU - HORIANA, BORDEAUX, France
LAUREN Inchboard - HORIANA, BORDEAUX, France
MATHIAS Vacheret - VACCINES MEDICAL, PFIZER, PARIS, France
Détails de publication: Value in health, Vol.28(12), pp.S289-S289
Éditeur: Elsevier Inc
Identifiants: 99148980709311
Unité académique: Virulence Bacterienne et Infections Chroniques - VBIC
Langue: English
Type de ressource: Journal article